DE-PHARMA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
21-05
micro format · 71 days before the deadline
2025
28-05
micro format · 64 days before the deadline
2024
21-05
micro format · 71 days before the deadline
2023
03-08
Gazette deed
Reappointment: Philippe De Broux (director)2 points ▸
Gazette deed
Reappointment: Philippe De Broux (director)
2 points ▸
- General meeting, 10-05-2023
- Director reappointment, Philippe De Broux (director)
15-06
micro format · 46 days before the deadline
2022
14-06
micro format · 47 days before the deadline
2021
31-12
Financial
Highest result from 2018 to 2025net €964,987 ▲12,456%
The net result of €964,987 is the highest of those years.
31-12
Financial
Liquidity more than 51 timescurrent ratio 4.37
The current ratio rises from 0.08 to 4.37. Short-term debt falls from €864,166 to €294,413.
31-12
Financial
Equity above €1mequity €1.1m ▲534%
With a profit in every financial year since 2018, equity grows to €1.1m.
14-05
micro format · 78 days before the deadline
2020
31-12
Financial
Weakest financial yearnet €7,686 ▼63.1%
The net result drops to €7,686, the lowest from 2018 to 2025. It recovers the following year.
25-05
micro format · 67 days before the deadline
Show earlier events
2019
14-05
micro format · 78 days before the deadline
2018
04-06
micro format · 57 days before the deadline
2017
06-06
full format · 55 days before the deadline
2004
14-12
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank